Multiple biomarker strategies in coronary artery disease

被引：0
|
作者：
Raizner, Albert E.
de Lemos, James A.
机构：
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
There are a host of potential biomarker targets in acute coronary syndrome (ACS), including markers of inflammation, thrombosis, endothelial activation, ischemia, plaque rupture, necrosis, arrhythmias, and neurohormonal activation (Slide 1). Many of these biomarkers have been identified through the rapidly growing fields of genomics and proteomics. Now, the question becomes: What do these biomarkers add to our understanding of cardiovascular disease (CVD), and how do they figure into the treatment puzzle?
引用
收藏
页码：CS1 / CS6
页数：6
相关论文
共 50 条
  • [41] MiR-15a Functions as a Diagnostic Biomarker for Coronary Artery Disease
    Pan, Xiaodong
    He, Yanru
    Ling, Sunkai
    Chen, Zhongpu
    Yan, Gaoliang
    CLINICAL LABORATORY, 2020, 66 (08) : 1509 - 1515
  • [42] Cost-effective biomarker for coronary artery disease: time to move on
    Roy, Ambuj
    Prabhakaran, D.
    Sniderman, Allan D.
    CURRENT SCIENCE, 2009, 97 (03): : 392 - 396
  • [43] Leukocyte telomere length: a potential biomarker for the prognosis of coronary artery disease
    Sun, Ying
    Wang, Wei
    Jiao, Yue-Ru
    Ren, Jian
    Gao, Lei
    Li, Yang
    Hu, Ping
    Ren, Tian-Ying
    Han, Qian-Feng
    Chen, Chen
    Yao, Heng-Chen
    BIOMARKERS IN MEDICINE, 2020, 14 (11) : 933 - 941
  • [44] Pentraxin-3 a novel biomarker for predicting coronary artery disease
    Yigit, S.
    Sari, S.
    Canbolat, I. P.
    Ozkan, A. Arat
    Ersanli, M. K.
    Gurmen, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 566 - 566
  • [45] Inflammation and coronary artery disease: as a new biomarker neutrophil/lymphocyte ratio
    Kaya, Mehmet Gungor
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 (03): : 191 - 192
  • [46] Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance
    Ferrannini, Ele
    Marx, Nikolaus
    Andreini, Daniele
    Campi, Beatrice
    Saba, Alessandro
    Gorini, Marco
    Ferrannini, Giulia
    Milzi, Andrea
    Magnoni, Marco
    Maseri, Attilio
    Maggioni, Aldo P.
    Burgmaier, Mathias
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 346 : 86 - 92
  • [47] Circulating epigenetic biomarker profiling for early diagnosis of coronary artery disease
    Vierlinger, Klemens
    Hofner, Manuela
    Yousaf, Iqra
    Gruber, Nina
    Hendling, Michaela
    Vignolle, Gabriel
    Pulverer, Walter
    Weinhaeusel, Andreas
    Tscharre, Maximilian
    Roithinger, Franz Xaver
    Noehammer, Christa
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 726 - 726
  • [48] Plasma miR-10a: A Potential Biomarker for Coronary Artery Disease
    Luo, Liyun
    Chen, Bairong
    Li, Songbiao
    Wei, Xiaoliang
    Liu, Tianmin
    Huang, Yin
    Lin, Xiufang
    DISEASE MARKERS, 2016, 2016 : 1 - 5
  • [49] Circulating cathepsin K as a potential novel biomarker of coronary artery disease
    Cheng, Xian Wu
    Kikuchi, Ryosuke
    Ishii, Hideki
    Yoshikawa, Daiji
    Hu, Lina
    Takahashi, Ryotaro
    Shibata, Rei
    Ikeda, Nobuo
    Kuzuya, Masafumi
    Okumura, Kenji
    Murohara, Toyoaki
    ATHEROSCLEROSIS, 2013, 228 (01) : 211 - 216
  • [50] Subclinical coronary artery disease in multiple sclerosis patients
    Andreadou, E.
    Gerakoulis, S.
    Haina, V.
    Katsavos, S.
    Evangelopoulos, M-E
    Koutsis, G.
    Anagnostouli, M.
    Stamboulis, E.
    Kilidireas, C.
    Gialafos, E.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 153 - 154
12345